MMV North America Inc. Board

MMV North America Inc. was created as a non-profit corporation to support the projects and programmes of Medicines for Malaria Venture (Switzerland).

MMV North America Inc. Board Members

Mr Ray Chambers, Special Envoy for Financing of the Health-Related Millennium Development Goals, co-founder of Malaria No More

Dr David Bowen, Independent Advisor, USA

Dr David Reddy, CEO, MMV, Switzerland

Dr Dennis Schmatz, President of the Board of North America Inc., Co-Chairman, MMV ESAC (Discovery), former Vice President, Head of Tsukuba Research Institute, Merck-Banyu Research Laboratories, Japan

Ms Wendy Taylor, Director, Center for Accelerating Innovation and Impact at USAID, USA

Former MMV North America Inc. Board Members

Dr J Carl Craft, former Chief Scientific Officer, MMV Switzerland

Dr Christopher J. Elias, President, PATH - Program for Appropriate Technology in Health, USA

Dr Chris Hentschel, President and Chief Executive Officer, Medicines for Malaria Venture (MMV), Switzerland

Mr Jim Geraghty, Senior Vice-President, Genzyme Corporation, USA